Skip to main content
. 2021 Sep 12;2021:6610529. doi: 10.1155/2021/6610529

Figure 7.

Figure 7

Analysis of HSP60 phosphorylation at residue Ser70 in human ovarian cancer tissue mitochondrial samples with mass spectrometry and in ovarian cancer cell TOV-21G with immunoprecipitation and western blot. (a) The MS/MS spectrum of phosphopeptide TVIIEQSWGS∗PK (S∗ = phosphoserine) derived from HSP60 in ovarian cancer tissues. (b) HSP60 was immunoprecipitated with an anti-HSP60 antibody, followed by phosphorylation analysis of immunoprecipitated HSP60 with western blot against the anti-phosphoserine antibody at residue Ser70 of HSP60 in ovarian cancer cells TOV-21G.